Lupron depot generic name?

What is Lupron Depot's generic name, and how will it affect patients?

Lupron Depot is a brand name medication used to treat conditions like prostate cancer, precocious puberty, and endometriosis. It contains the active ingredient leuprolide acetate.

Why are companies challenging this patent?

There is no patent expiration data currently available for leuprolide acetate, so we can't provide any information about patent expiration dates. However, generic versions of leuprolide acetate have been available in the United States since 2019, approved by the FDA. [1]

How does this drug compare with Keytruda?

Lupron Depot and Keytruda (pembrolizumab) are two distinct medications with different mechanisms of action and indications. Keytruda is a PD-1 inhibitor used to treat various types of cancer, including melanoma, lung cancer, and head and neck cancer. Lupron Depot is used to treat hormone-sensitive cancers and other conditions by suppressing hormone production.

What are the side effects associated with Lupron Depot?

Common side effects of Lupron Depot include hot flashes, injection site reactions, and sleep disturbances. The medication can also cause changes in blood cholesterol and triglyceride levels. For detailed information about the side effects, refer to the medication guide provided by your healthcare provider or the FDA. [2]

Can biosimilars enter before patent expiry?

As the patent does not provide information for a specific patent expiration for leuprolide acetate, biosimilars or even new leuprolide acetate generics are available since 2019. However, it is worth noting that the patent expiration would depend on regulatory factors.

Sources:

[1] DrugPatentWatch.com: leuprolide acetate FDA approval

[2] FDA.gov: Leuprolide injection (Leuprolide Acetate Injectable Suspension)

Sources Cited: